NextCure, Inc. (NXTC) Misses Q3 EPS by 6c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Southern Co. (SO) PT Lowered to $99 at Jefferies
• SpaceX (SPCX) call put ratio 1.1 calls to 1 put as share price down 9.8%